The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation

Cancer Research

Volumn 72, Issue 18, 2012, Pages 4846-4855

  Mitchell, James B ^a   Anver, Miriam R ^c   Sowers, Anastasia L ^a   Rosenberg, Philip S ^a   Figueroa, Maria ^a   Thetford, Angela ^a   Krishna, Murali C ^a   Albert, Paul S ^b   Cook, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC RESTRICTION; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; HEMATOPOIETIC SYSTEM TUMOR; LIFESPAN; LYMPHOMA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RISK REDUCTION; SECOND CANCER; THERAPY EFFECT; TREATMENT RESPONSE; WEIGHT REDUCTION; WHOLE BODY RADIATION;

ANIMALS; ANTIOXIDANTS; CYCLIC N-OXIDES; FEMALE; MICE; NEOPLASMS, RADIATION-INDUCED; RADIATION-PROTECTIVE AGENTS; SPIN LABELS; WHOLE-BODY IRRADIATION;

EID: 84866375872     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1879     Document Type: Article

References (49)

1. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
2. Kohn HI, Fry RJ. Radiation carcinogenesis. N Engl J Med 1984;310:504-11.
3. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28.
4. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010;15:360-71.
5. Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol 2010;20:67-78.
6. Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011;11:438-48.
7. Patt HM, Tyree EB, Staube RL, Smith DE. Cysteine protection against X-irradiation. Science 1949;110:213-4.
8. Yuhas JM, Storer VB. Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst 1969;42:331-5.
9. Weiss JF, Landauer MR. History and development of radiation-protective agents. Int J Radiat Biol 2009;85:539-73.
10. Gross L, Dreyfuss Y. Reduction in the incidence of radiation-induced tumors in rats after restriction of food intake. Proc Natl Acad Sci U S A 1984;81:7596-8.
11. Gross L, Dreyfuss Y. Inhibition of the development of radiation-induced leukemia in mice by reduction of food intake. Proc Natl Acad Sci U S A 1986;83:7928-31.
12. Yoshida K, Inoue T, Nojima K, Hirabayashi Y, Sado T. Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc Natl Acad Sci 1997;94:2615-9.
13. Racette SB, Weiss EP, Villareal DT, Arif H, Steger-May K, Schechtman KB, et al. One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci 2006;61:943-50.
14. Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, et al. The chemistry and biology of nitroxide compounds. Free Radic Biol Med 2007;42:1632-50.
15. Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, et al. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med 2003;34:93-102.
16. Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, et al. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet 2004;13:1793-802.
17. Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, et al. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet 2005;14:1699-708.
18. Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, Finegold M, et al. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res 2008;68:1601-8.
19. Gaynor JJ, Feuer EJ, Tan CC, WU DH, Little CR, Straus DJ, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-9.
20. Cook JA, Chuang EY, Tsai MH, Coffin D, Degraff W, Sowers AL, et al. Radiation-induced changes in gene-expression profiles for the SCC VII tumor cells grown in vitro and in vivo. Antioxid Redox Signal 2006;8:1263-72.
21. Drinkwater NR, Ginsler JJ. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 1986;7:1701-7.
22. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 1996;146:1-27.
23. Zhang YK, Saupe KW, Klaassen CD. Energy restriction does not compensate for the reduced expression of hepatic drug-processing genes in mice with aging. Drug Metab Dispos 2010;38:1122-31.
24. Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med 2011;32:159-221.
25. Forster MJ, Morris P, Sohal RS. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J 2003;17:690-2.
26. Losonczy KG, Harris TB, Cornoni-Huntley J, Simonsick EM, Wallace RB, Cook NR, et al. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? Am J Epidemiol 1995;141:312-21.
27. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001;49:1309-18.
28. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 1997;57:4667-72.
29. Samuni Y, Cook JA, Choudhuri R, Degraff W, Sowers AL, Krishna MC, et al. Inhibition of adipogenesis by Tempol in 3T3-L1 cells. Free Radic Biol Med 2010;49:667-73.
30. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, et al. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 2009;100:578-82.
31. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18.
32. Umemoto Y, Tsuji K, Yang FC, Ebihara Y, Kaneko A, Furukawa S, et al. Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood 1997;90:3438-43.
33. Yun JP, Behan JW, Heisterkamp N, Butturini A, Klemm L, Ji L, et al. Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models. Cancer Prev Res (Phila) 2010;3:1259-64.
34. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
35. Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M, et al. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer 1999;80:494-6.
36. Hursting SD, Switzer BR, French JE, Kari FW. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res 1993;53:2750-7.
37. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-52.
38. Schmucker DL. Aging and drug disposition: an update. Pharmacol Rev 1985;37:133-48.
39. Park SK, Kim K, Page GP, Allison DB, Weindruch R, Prolla TA. Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. Aging Cell 2009;8:484-95.
40. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990;29:2802-7.
41. Clutton SM, Townsend KM, Walker C, Ansell JD, Wright EG. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis 1996;17:1633-9.
42. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
43. Ponnaiya B, Cornforth MN, Ullrich RL. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat Res 1997;147:121-5.
44. Randall K, Coggle JE. Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation. Int J Radiat Biol 1996;70:351-60.
45. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000;47:277-90.
46. Lorimore SA, Mukherjee D, Robinson JI, Chrystal JA, Wright EG. Longlived inflammatory signaling in irradiated bone marrow is genome dependent. Cancer Res 2011;71:6485-91.
47. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.
48. Hail NJ, Cortes M, Drake EN, Spallholz JE. Cancer chemoprevention: a radical perspective. Free Radic Biol Med 2008;45:97-110.
49. Kennedy AR. Factors that modify radiation-induced carcinogenesis. Health Phys 2009;97:433-45.